Report Detail
Global Allergy Immunotherapy Market Insights, Forecast to 2025
- RnM2451722 |
- 11 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The global Allergy Immunotherapy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Allergy Immunotherapy market based on company, product type, end user and key regions.
This report studies the global market size of Allergy Immunotherapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Allergy Immunotherapy in these regions.
This research report categorizes the global Allergy Immunotherapy market by top players/brands, region, type and end user. This report also studies the global Allergy Immunotherapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
Market size by Product
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market size by End User
Allergic Rhinitis
Allergic Asthma
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Allergy Immunotherapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Allergy Immunotherapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Allergy Immunotherapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Allergy Immunotherapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Allergy Immunotherapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Allergy Immunotherapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Allergy Immunotherapy Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Allergy Immunotherapy Market Size Growth Rate by Product
- 1.4.2 Subcutaneous Immunotherapy
- 1.4.3 Sublingual Immunotherapy
- 1.5 Market by End User
- 1.5.1 Global Allergy Immunotherapy Market Size Growth Rate by End User
- 1.5.2 Allergic Rhinitis
- 1.5.3 Allergic Asthma
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Allergy Immunotherapy Market Size
- 2.1.1 Global Allergy Immunotherapy Revenue 2014-2025
- 2.1.2 Global Allergy Immunotherapy Sales 2014-2025
- 2.2 Allergy Immunotherapy Growth Rate by Regions
- 2.2.1 Global Allergy Immunotherapy Sales by Regions
- 2.2.2 Global Allergy Immunotherapy Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Allergy Immunotherapy Sales by Manufacturers
- 3.1.1 Allergy Immunotherapy Sales by Manufacturers
- 3.1.2 Allergy Immunotherapy Sales Market Share by Manufacturers
- 3.1.3 Global Allergy Immunotherapy Market Concentration Ratio (CR5 and HHI)
- 3.2 Allergy Immunotherapy Revenue by Manufacturers
- 3.2.1 Allergy Immunotherapy Revenue by Manufacturers (2014-2019)
- 3.2.2 Allergy Immunotherapy Revenue Share by Manufacturers (2014-2019)
- 3.3 Allergy Immunotherapy Price by Manufacturers
- 3.4 Allergy Immunotherapy Manufacturing Base Distribution, Product Types
- 3.4.1 Allergy Immunotherapy Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Allergy Immunotherapy Product Type
- 3.4.3 Date of International Manufacturers Enter into Allergy Immunotherapy Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Allergy Immunotherapy Sales by Product
- 4.2 Global Allergy Immunotherapy Revenue by Product
- 4.3 Allergy Immunotherapy Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Allergy Immunotherapy Breakdown Data by End User
6 North America
- 6.1 North America Allergy Immunotherapy by Countries
- 6.1.1 North America Allergy Immunotherapy Sales by Countries
- 6.1.2 North America Allergy Immunotherapy Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Allergy Immunotherapy by Product
- 6.3 North America Allergy Immunotherapy by End User
7 Europe
- 7.1 Europe Allergy Immunotherapy by Countries
- 7.1.1 Europe Allergy Immunotherapy Sales by Countries
- 7.1.2 Europe Allergy Immunotherapy Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Allergy Immunotherapy by Product
- 7.3 Europe Allergy Immunotherapy by End User
8 Asia Pacific
- 8.1 Asia Pacific Allergy Immunotherapy by Countries
- 8.1.1 Asia Pacific Allergy Immunotherapy Sales by Countries
- 8.1.2 Asia Pacific Allergy Immunotherapy Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Allergy Immunotherapy by Product
- 8.3 Asia Pacific Allergy Immunotherapy by End User
9 Central & South America
- 9.1 Central & South America Allergy Immunotherapy by Countries
- 9.1.1 Central & South America Allergy Immunotherapy Sales by Countries
- 9.1.2 Central & South America Allergy Immunotherapy Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Allergy Immunotherapy by Product
- 9.3 Central & South America Allergy Immunotherapy by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Allergy Immunotherapy by Countries
- 10.1.1 Middle East and Africa Allergy Immunotherapy Sales by Countries
- 10.1.2 Middle East and Africa Allergy Immunotherapy Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Allergy Immunotherapy by Product
- 10.3 Middle East and Africa Allergy Immunotherapy by End User
11 Company Profiles
- 11.1 ALK-Abello
- 11.1.1 ALK-Abello Company Details
- 11.1.2 Company Business Overview
- 11.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 ALK-Abello Allergy Immunotherapy Products Offered
- 11.1.5 ALK-Abello Recent Development
- 11.2 Stallergenes Greer
- 11.2.1 Stallergenes Greer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Stallergenes Greer Allergy Immunotherapy Products Offered
- 11.2.5 Stallergenes Greer Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Allergy Immunotherapy Products Offered
- 11.3.5 Merck Recent Development
- 11.4 Allergy Therapeutics
- 11.4.1 Allergy Therapeutics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Allergy Therapeutics Allergy Immunotherapy Products Offered
- 11.4.5 Allergy Therapeutics Recent Development
- 11.5 HAL
- 11.5.1 HAL Company Details
- 11.5.2 Company Business Overview
- 11.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 HAL Allergy Immunotherapy Products Offered
- 11.5.5 HAL Recent Development
- 11.6 WOLW Pharma
- 11.6.1 WOLW Pharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 WOLW Pharma Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 WOLW Pharma Allergy Immunotherapy Products Offered
- 11.6.5 WOLW Pharma Recent Development
- 11.7 Holister Stier
- 11.7.1 Holister Stier Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Holister Stier Allergy Immunotherapy Products Offered
- 11.7.5 Holister Stier Recent Development
- 11.8 Leti
- 11.8.1 Leti Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Leti Allergy Immunotherapy Products Offered
- 11.8.5 Leti Recent Development
12 Future Forecast
- 12.1 Allergy Immunotherapy Market Forecast by Regions
- 12.1.1 Global Allergy Immunotherapy Sales Forecast by Regions 2019-2025
- 12.1.2 Global Allergy Immunotherapy Revenue Forecast by Regions 2019-2025
- 12.2 Allergy Immunotherapy Market Forecast by Product
- 12.2.1 Global Allergy Immunotherapy Sales Forecast by Product 2019-2025
- 12.2.2 Global Allergy Immunotherapy Revenue Forecast by Product 2019-2025
- 12.3 Allergy Immunotherapy Market Forecast by End User
- 12.4 North America Allergy Immunotherapy Forecast
- 12.5 Europe Allergy Immunotherapy Forecast
- 12.6 Asia Pacific Allergy Immunotherapy Forecast
- 12.7 Central & South America Allergy Immunotherapy Forecast
- 12.8 Middle East and Africa Allergy Immunotherapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Allergy Immunotherapy Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Allergy Immunotherapy . Industry analysis & Market Report on Allergy Immunotherapy is a syndicated market report, published as Global Allergy Immunotherapy Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Allergy Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
